In conclusion, the supplementation of newly diagnosed breast cancer patients with 1.8 g of EPA and DHA for 30 days led to a significant change in the composition of plasma fatty acids, maintained the level of CD4+ T cells and serum levels of CRP, suggestive of a beneficial effect on the immune system. Here, CD4 is linked to breast cancer.